Related Experiment Videos
Antimycotic 2-alkyldithio, 2-aralkyldithio, 2-aryldithiobenzamides
Il Farmaco; Edizione Scientifica
|November 1, 1985
Summary
New antifungal compounds, specifically N-monosubstituted amides derived from benzoic acid, show promising activity against Candida albicans and Trichophyton mentagrophytes, comparable to existing antifungals.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Antimicrobial Research
Background:
- Fungal infections caused by Candida albicans and Trichophyton mentagrophytes pose significant health challenges.
- Development of novel antifungal agents is crucial due to rising resistance to existing therapies.
Purpose of the Study:
- To synthesize and evaluate the in vitro antifungal activity of novel 2-substituted dithio benzoic acid derivatives.
- To compare the efficacy of these new compounds with established antifungal drugs.
Main Methods:
- Synthesis of various 2-alkyldithio, 2-aralkyldithio, and 2-aryldithio benzoic acids, their methyl esters, and N-monosubstituted amides.
- In vitro testing of synthesized compounds against Candida albicans and Trichophyton mentagrophytes.
- Comparative analysis of antifungal activity against standard drugs like clotrimazole and pyrrolnitrin.
Main Results:
- Several N-monosubstituted amides demonstrated significant antifungal activity.
- The observed activity of some N-monosubstituted amides was comparable to that of clotrimazole and pyrrolnitrin.
- N-monosubstituted amides showed generally higher activity against Candida albicans compared to related compounds derived from 2,2'-dicarboxydiphenyldisulfide.
Conclusions:
- The synthesized N-monosubstituted amides represent a promising class of novel antifungal agents.
- These compounds exhibit potent in vitro activity against key fungal pathogens.
- Further investigation is warranted to explore their therapeutic potential for fungal infections.